Evaluated treatment approaches in child and adolescent psychiatry II;Evaluierte behandlungsansätze in der kinder- und jugendpsychiatrie II

Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie

Volumn 29, Issue 3, 2001, Pages 206-220

  Baving, L ^a   Schmidt, M H ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Controlled study; Evaluation; Evidence based medicine; Pharmacotherapy; Psychotherapy

Indexed keywords

CLOMIPRAMINE; CLOZAPINE; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; LITHIUM; PSYCHOTROPIC AGENT; SERTRALINE;

AFFECTIVE NEUROSIS; ANOREXIA NERVOSA; ANXIETY NEUROSIS; BEHAVIOR THERAPY; BULIMIA; CHILD PSYCHIATRY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EATING DISORDER; EVIDENCE BASED MEDICINE; HUMAN; OBSESSION; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCHIZOPHRENIA;

ADOLESCENT; ADULT; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; MENTAL DISORDERS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS;

EID: 0034908199     PISSN: 14224917     EISSN: None     Source Type: Journal    
DOI: 10.1024//1422-4917.29.3.206     Document Type: Review

References (133)

1. A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia netvosa
2. Multicenter open-label sertraline study in adolescent outpatients with major depression
3. Risperidone in adolescents with schizophrenia: An open pilot study
4. Combination of antidepressants and psychological treatments for bulimia nervosa: A systematic review
5. Fluvoxamine for phobia of storms
6. Evaluation of cognitive-behavioral group treatments for childhood anxiety disorders
7. The present status of operant conditioning for the treatment of anorexia nervosa
8. Imipramine plus cognitive-behavioral therapy in the treatment of school refusal
9. Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder
10. Randomized, controlled trial of amitriptyline versus placebo for adolescents with «treatment-resistant» major depression
11. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial
12. Treatment of cognitive dysfunctions and behavioral deficits in schizophrenia
13. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy
14. A variation of thought stopping in a twelve-year-old boy: A case report
15. Pulse clomipramine for depressed adolescents
16. Is valproate pharmacotherapy associated with polycystic ovaries?
17. Cognitive-behavioral treatment of adolescent depression: Efficacy of acute group treatment and booster sessions
18. Effects of psychoeducational intervention for married patients with bipolar disorder and their spouses
19. An auditory variant of eye movement desensitization in a case of childhood post-traumatic stress disorder
20. A treatment outcome study for sexually abused preschool children: Initial findings
21. A treatment study for sexually abused preschool children: Outcome during a one-year follow-up
22. The effectiveness of emotive imagery in the treatment of darkness phobia in children
23. Exposure therapy, fluvoxamine, or combination treatment in obsessive-compulsive disorder: One-year follow-up
24. Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents
25. Differential symptom reduction by drugs and psychotherapy in acute depression
26. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression
27. Open fluoxetine treatment of mixed anxiety disorders in children and adolescents
28. Three psychological treatments for bulimia nervosa. A comparative trial
29. Psychotherapy and bulimia nervosa. Longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavior therapy
30. A prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments
31. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two-year longitudinal study
32. Propanolol treatment for childhood posttraumatic stress disorder, acute type
33. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: A randomised, double-blind trial
34. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents
35. Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder
36. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study
37. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial
38. Childhood obsessive-compulsive disorder: Extinction of compulsive reassurance seeking
39. Risperidone treatment for juvenile bipolar disorder: A retrospective chart review
40. Hypnotherapy with traumatized children
41. Intermittent medication - An alternative?
42. Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a «fixed plasma level» design
43. Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder
44. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency
45. Controlled imipramine treatment of school phobia
46. Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression
47. Long-term fluoxetine treatment of bulimia nervosa
48. Clonazepam in childhood anxiety disorders
49. Family self-control instruction for children's nighttime rear reduction
50. Behavioral treatment of «night-fears» in children: Maintenance of improvement at 21/2- to 3-year follow-up
51. Clonidine for posttraumatic stress disorder in preschool children
52. Cognitive-behavioral group therapy for social phobia in female adolescents: Results of a pilot study
53. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. I. One-year effects of a controlled study on relapse and expressed emotion
54. Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multicentre study
55. Psychoeducation in bipolar disorder: Effect on expressed emotion
56. Guanfacine for PTSD nightmares
57. Moclobemide in social phobia. A double-blind, placebo-controlled clinical study
58. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy
59. Reduction of children's fear of the dark by competence-related and situational threat-related verbal cues
60. Compliance therapy in psychotic patients: Randomised controlled trial
61. Randomined controlled trial of compliance therapy. 18-Month follow-up
62. Therapy for youths with anxiety disorders: A second randomized clinical trial
63. Verhaltenstherapie schizophrener jugendlicher
64. Treating sexually abused children with posttraumatic stress symptoms: A randomised clinical trial
65. Adolescent depression: Controlled desipramine treatment and atypical features
66. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder
67. Use of buspirone in an adolescent with overanxious disorder
68. Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison
69. Childhood-onset schizophrenia: An open-label study of olanzapine in adolescents
70. Successful clonazepam treatment of adolescents with panic disorder
71. Response to desipramine treatment in adolescent depression: A fixed-dose, placebo-controlled trial
72. A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression
73. A controlled trial of social intervention in the families of schizophrenic patients: Two year follow-up
74. A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder
75. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison
76. Citalopram in the treatment of early-onset panic disorder and school phobia
77. A comparison of behavior therapy techniques in the reduction of fearful avoidance behavior
78. Skills training versus psychosocial occupational therapy for persons with persistent schizophrenia
79. Duration of psychosis and outcome in first-episode schizophrenia
80. Carbamazepine for PTSD
81. Serotonergic agents in the treatment of social phobia in children and adolescents: A case series
82. Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial
83. Two-year outcome of social skills training and group psychotherapy for out-patients with schizophrenia
84. Behaviour therapy for obsessive-compulsive disorder: A decade of progress
85. Schizophrenia - A follow-up study of results of treatment
86. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: An open-label trial in adolescents with psychotic disorders
87. Symptom-specific effects of fluoxetine in post-traumatic stress disorder
88. Cognitive-behavioral group treatments in childhood anxiety disorders: The role of parental involvement
89. A comparison of in vivo and vicarious exposure in the treatment of childhood water phobia
90. A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa
91. Interpersonal psychotherapy for depressed adolescents
92. Efficacy of interpersonal psychotherapy for depressed adolescents
93. Eye movement desensitisation and reprocessing versus exposure in vivo. A single-session crossover study of spider-phobic children
94. An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without poststreptococcal exacerbations
95. An open trial of paroxetine in the treatment of children and adolescents diagnosed with dysthymia
96. Treatment of a bodily injury phobia with implosive therapy
97. Improvement of some schizophrenic deficit symptoms with low doses of amisulpride
98. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood
99. Imipramine in prepubertal major depressive disorders
100. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: Clinical symptoms and functional impairments
101. Paroxetine in children with major depressive disorder: An open trial
102. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder
103. Obsessive-compulsive disorder in children and adolescents
104. The group desensitization of children's snake phobias using vicarious and contact desensitization procedures
105. A controlled comparison of family versus individual therapy for adolescents with anorexia nervosa
106. Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder
107. The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents
108. Pulse intravenous clomipramine for depressed adolescents: Double-blind, controlled trial
109. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication
110. Treating adolescent obsessive-compulsive disorder: Applications of the cognitive theory
111. A comparison of graduated exposure, verbal coping skills, and their combination in the treatment of children's fear of the dark
112. Treatment of childhood-onset schizophrenia with olanzapine
113. Alprazolam effects in children with anxiety disorders
114. Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders
115. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination
116. Bipolar disorder and family communication: Effects of a psychoeducational treatment program
117. Olanzapine in the treatment of adolescent acute mania: A report of seven cases
118. The treatment of childhood social phobia: The effectiveness of a social skills training-based, cognitive-behavioural intervention, with and without parental involvement
119. Haloperidol in schizophrenic children: Early findings from a study in progress
120. Bipolar disorder in children and adolescents: Current challenges
121. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: A naturalistic disorder
122. Pediatric autoimmune neuropsychiatric disorders associated with strepto-coccal infections: Clinical description of the first 50 cases
123. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia
124. Child and adolescent obsessive-compulsive disorder treated with citalopram: Findings from an open trial of 23 cases
125. The reduction of anxiety in children: A comparison of the effects of «systematic desensitization in vitro» and «systematic desensitization in vivo»
126. Fluoxetine in posttraumatic stress disorder
127. Cognitive remediation
128. The long-term treatment of social phobia with moclobemide
129. Long-term outcome of antidepressant treatment for bulimia nervosa
130. Medication and psychotherapy in the treatment of bulimia nervosa
131. Open trial of fluoxetine in children and adolescents with dysthymic disorder or double depression
132. Valproic acid for dysphoric mania in a mentally retarded adolescent